DIGIFAB
What it isDigoxin-specific antibody fragments; digoxin toxicity.
Why this oneIt binds digoxin directly and reverses arrhythmia and hyperkalemia within an hour.
What limits itTotal digoxin assays become useless afterwards because they measure bound drug. Rebound toxicity if dosing is inadequate.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Digoxin toxicity — acute ingestion, unknown amount, no serum level | All | 20 vials IV (children <20 kg: start 10 vials, then 10 more if needed) | ||
| Chronic digoxin toxicity — no serum level | Adults & children ≥20 kg | 6 vials IV | ||
| Chronic digoxin toxicity — no serum level | Infants & children <20 kg | 1 vial IV | ||
| Acute ingestion of known amount | All | Vials = mg digoxin ingested ÷ 0.5 mg/vial | ||
| Chronic toxicity with known serum level | All | Vials = (serum digoxin ng/mL × weight kg) ÷ 100 |
Renal Fab fragments are eliminated renally; impaired renal function may prolong elimination — monitor for recurrent toxicity.
Hepatic Undefined
Dose according to the amount of digoxin to be neutralized (0.5 mg neutralized per vial).
Pregnancy No human or animal data; use only if clearly needed.
Lactation Unknown whether excreted in human milk; exercise caution in nursing mothers.
NO BOXED WARNINGS
Principal riskDigoxin assays become uninterpretable afterwards
